NCT01526733: Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase |
|
|
| Completed | 4 | 25 | US | Sham Injection, Recombinant human hyaluronidase PH20, rHuPH20, PH20, Hylenex, Insulin aspart, Novolog, Aspart, Insulin lispro, Humalog, Lispro | Halozyme Therapeutics | Type 1 Diabetes Mellitus | 08/12 | 09/13 | | |
